Non small cell lung cancer

• Health & Medicine

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China. A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

19 May 2017

• Science & Technology
• Health & Medicine

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

26 April 2017

• Health & Medicine

Immunotherapy drug extends lives of advanced lung cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects. A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects.

13 December 2016

• Health & Medicine

Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer

Syncona LLP and Cancer Research Technology (CRT) announce the formation of Achilles Therapeutics Ltd today. Syncona LLP and Cancer Research Technology (CRT) announce the formation of Achilles Therapeutics Ltd today.

5 October 2016

• Health & Medicine

Lung cancer patients whose tumour has spread to the brain could be spared radiotherapy

Patients with non-small cell lung cancer which has spread to the brain could be spared whole brain radiotherapy. Patients with non-small cell lung cancer which has spread to the brain could be spared whole brain radiotherapy.

4 September 2016

• Science & Technology
• Health & Medicine

Scientists discover drug combination slows lung cancer cell growth

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab. Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.

24 August 2016

• Health & Medicine

Doubling-up on cancer immunotherapy shows promise, but side effects still a challenge

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer. A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.

4 June 2016

• Science & Technology
• Health & Medicine

US hospital commits to lung cancer ‘liquid biopsy’

Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer. Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.

8 April 2016

• Health & Medicine

Thousands of patients missing out on targeted cancer drugs

Thousands of cancer patients are missing out on personalised treatments each year because they are not being tested to see if they might benefit from them Thousands of cancer patients are missing out on personalised treatments each year because they are not being tested to see if they might benefit from them

20 August 2015

• Health & Medicine

Immunotherapy drugs show continued promise

A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference. A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference.

1 June 2015

Body’s cancer defences hijacked to make pancreatic and lung cancers more aggressive

Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked. Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked.

2 April 2015

• Health & Medicine

Scientists trigger self-destruct switch in lung cancer cells

Scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells. Scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells.

31 October 2014